Results 161 to 170 of about 101,101 (329)
A Case Report on Canine Prostatic Adenocarcinoma Accompanied by Hematuria
Katsumi HAMANA+2 more
openalex +2 more sources
Cytological Assessment of Adrenal Tumours: Insights From 22‐Years Single Centre Experience
ABSTRACT Objective The incidence of adrenal tumours has increased in the last decades, mainly due to increased use of imaging. The diagnostic evaluation of adrenal masses can be complex and, in some cases, necessitates cytological evaluation. However, concerns remain regarding the potential complications associated with adrenal gland biopsy.
Ana Carasel+3 more
wiley +1 more source
The Occult Hematuria Test in the Mass Examination
Masaya Konuma, Kenkichi SYOONAKA
openalex +2 more sources
Malignant hypertension (MHT) is a rare, severe condition with high morbidity and mortality. Using data from 385 patients in the West Birmingham MHT Registry, this study evaluated nine machine learning (ML) algorithms to predict a composite outcome of all‐cause mortality/dialysis over a median 11‐year follow‐up.
Antonios A. Argyris+7 more
wiley +1 more source
Erratum to : Studies on Chronic Bovine Hematuria Vesicalis Due to Tumors
openalex +2 more sources
BJU International, Volume 135, Issue 5, Page 743-747, May 2025.
Lorenzo Pierangelo Treccani+8 more
wiley +1 more source
The evolving role of positron emission tomography in precision prostate cancer biopsy
Prostate biopsy plays a pivotal role in the detection and characterization of prostate cancer. PSMA PET‐targeted biopsy represents a significant advancement in prostate cancer diagnostics, offering higher sensitivity, specificity and accuracy in detecting clinically significant lesions compared to traditional methods. PSMA PET, when combined with mpMRI,
Alessio Imperiale+11 more
wiley +1 more source
The Value of Cystoscopy as an Initial Diagnostic Modality for Asymptomatic Microscopic Hematuria [PDF]
Sung Kyu Hong, Curie Ahn, Hyeon Heo Kim
openalex +1 more source
Rilzabrutinib for the Treatment of Immune Thrombocytopenia
ABSTRACT Advancements in the understanding of ITP pathogenesis have led to significant improvements in disease management through the use of both traditional immunosuppressive strategies and novel targeted therapies. However, a subset of patients remains refractory to treatment or achieves only transient benefits, underscoring the need for alternative ...
Caterina Labanca+12 more
wiley +1 more source